EIF2A and Alzheimer disease: According to another study, increased levels of p-PKR, p-eIF2α, and p-mTOR were found in peripheral blood lymphocytes derived from AD patients compared to healthy subjects, in correlation with cognitive decline, further supporting the use of these molecules as biomarkers for the diagnosis of AD progression (Paccalin et al., 2006).